Swissmedic issues updates on reporting quality deficiencies and variations
This article was originally published in SRA
Executive Summary
Swiss drug regulator Swissmedic has revised its procedures for reporting quality deficiencies in order to adopt internationally applied standards to quality risk assessment1,2.